Read + Share
Amedeo Smart
Independent Medical Education
Zhu MY, Sun XS, Guo SS, Chen QY, et al. Do all patients with locoregionally advanced nasopharyngeal carcinoma benefit from the maintenance chemotherapy using S-1/capecitabine? Oral Oncol 2021;122:105539.PMID: 34547555
Email
LinkedIn
Facebook
Twitter
Privacy Policy